NCT01863069View on ClinicalTrials.gov

Avonex®: Safety, Blood Levels and Effects

PHASE1CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

October 31, 2001

Study Completion Date

October 31, 2001

Conditions
Multiple Sclerosis (MS)
Interventions
DRUG

Interferon beta 1a

DRUG

(IM) AVONEX®

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research, London

Sponsors

Collaborators (1)

Biogen
All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

Trio Medicines Ltd.

INDUSTRY